1343 / 1498
Progression-free survival (PFS) probability in rituximab-treated (red line) and splenectomized
patients (blue line) after 5 years.
Christina Kalpadakis et al. The Oncologist 2013;18:190-197
|
|
1343 / 1498
Progression-free survival (PFS) probability in rituximab-treated (red line) and splenectomized
patients (blue line) after 5 years.
Christina Kalpadakis et al. The Oncologist 2013;18:190-197